Jacob Friedman to Non-alcoholic Fatty Liver Disease
                            
                            
                                This is a "connection" page, showing publications Jacob Friedman has written about Non-alcoholic Fatty Liver Disease.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            3.919
         
        
        
     
 
    
        
        - 
            Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients. 2020 Oct 16; 12(10).
            
            
                Score: 0.639
             
- 
            The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat Commun. 2018 10 26; 9(1):4462.
            
            
                Score: 0.557
             
- 
            Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates. Mol Metab. 2018 12; 18:25-41.
            
            
                Score: 0.554
             
- 
            Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease. J Clin Invest. 2018 08 31; 128(9):3692-3703.
            
            
                Score: 0.551
             
- 
            Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J. 2017 04; 31(4):1434-1448.
            
            
                Score: 0.490
             
- 
            Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol. 2017 02; 14(2):81-96.
            
            
                Score: 0.485
             
- 
            Maternal Pyrroloquinoline Quinone Supplementation Improves Offspring Liver Bioactive Lipid Profiles throughout the Lifespan and Protects against the Development of Adult NAFLD. Int J Mol Sci. 2022 May 27; 23(11).
            
            
                Score: 0.179
             
- 
            Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
            
            
                Score: 0.166
             
- 
            Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. Diabetes. 2014 Aug; 63(8):2702-13.
            
            
                Score: 0.102
             
- 
            Developmental origins of nonalcoholic fatty liver disease. Pediatr Res. 2014 Jan; 75(1-2):140-7.
            
            
                Score: 0.099
             
- 
            Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". Clin Obstet Gynecol. 2013 Sep; 56(3):577-90.
            
            
                Score: 0.097